Current role
Biotechnology · Healthcare
Board Member
2026-06-09–present
Eric Bjerkholt, M.B.A.
Board Member
Metagenomi Therapeutics, Inc. (MGX)Equibles does not estimate personal net worth.
Get an email with a short summary when Metagenomi Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get MGX alertsAbout Eric Bjerkholt, M.B.A.
Eric Bjerkholt, M.B.A. is recorded as Board Member at Metagenomi Therapeutics, Inc. (MGX) since June 9, 2026. Metagenomi Therapeutics, Inc. reported in an 8-K filed June 10, 2026 that Eric Bjerkholt, M.B.A. was appointed Class II Director, effective June 9, 2026. Metagenomi Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Metagenomi Therapeutics, Inc. includes Jian Irish (CEO, COO and Board Member), Pamela Wapnick (CFO), Matthew L. Wein (General Counsel) and 5 others.
“Juergen Eckhardt, M.D., M.B.A. and Eric Bjerkholt, M.B.A. were elected as Class II Directors to serve until the Company's 2029 annual meeting of stockholders, and until their respective successor shall have been duly elected and qualified, or until their earlier death, resignation or removal, based on the following votes:”
Affiliation history
-
Current
2026-06-09–present
Company network
Leadership on record at Metagenomi Therapeutics, Inc.
- Jian Irish CEO, COO, Board Member
- Pamela Wapnick CFO
- Matthew L. Wein General Counsel
- Eric Bjerkholt Board Member
- Juergen Eckhardt Board Member
- Juergen Eckhardt, M.D., M.B.A. Board Member
- Laurence Reid Board Member
- Willard H. Dere Board Member